Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2018 Publisher: Mercury Pharmaceuticals Ltd., Capital House, 85 King William Street, London EC4N 7BL, UK
DIAMOX Sodium 500mg Powder for Solution for Injection.
Acetazolamide 500mg Powder for solution for Injection.
| Pharmaceutical Form |
|---|
|
White to off-white powder for solution for injection. |
Each vial contains Acetazolamide 500mg.
For full list of excipients see section 6.1.
| Active Ingredient |
|---|
|
Acetazolamide is an enzyme inhibitor which acts specifically on carbonic anhydrase. By inhibiting the reaction catalysed by this enzyme in the renal tubules, acetazolamide increases the excretion of bicarbonate and of cations, chiefly sodium and potassium, and so promotes alkaline diuresis. By inhibiting carbonic anhydrase in the eye acetazolamide decreases intra-ocular pressure and is therefore useful in the treatment of glaucoma. |
| List of Excipients |
|---|
|
Sodium hydroxide (for pH adjustment) Hydrochloric acid (for pH adjustment) |
Glass vial with butyl rubber plug and aluminium ring seal.
Pack size 500mg vial.
Mercury Pharmaceuticals Ltd., Capital House, 85 King William Street, London EC4N 7BL, UK
PL 12762/0146
11th February 1988 / 16th February 2004
| Drug | Countries | |
|---|---|---|
| DIAMOX | Austria, Australia, Brazil, Estonia, France, Croatia, Ireland, Japan, Netherlands, New Zealand, Tunisia, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.